From: Breast cancer surgery in elderly patients: postoperative complications and survival
 | N OF PATIENTS WITH COMPLICATION (%) | OR | 95% CI | p value |
---|---|---|---|---|
AGE | Â | Â | Â | Â |
65-69 | 13 (9,9%) | Ref | Â | Â |
70-74 | 15 (13,2%) | 1,37 | 0,58-3,24 | ns |
75-79 | 17 (19,5%) | 2,20 | 0,95-5,16 | ns |
80-84 | 18 (26,5%) | 3,27 | 1,40-7,72 | 0,004 |
> = 85 | 19 (38,8%) | 5,75 | 2,38-14,04 | <0,001 |
N OF CONCOMITANT DISEASE | Â | Â | Â | Â |
0 | 13 (12,0%) | Ref | Â | Â |
1 | 20 (18,3%) | 1,67 | 0,74-3,80 | ns |
2 | 20 (18,5%) | 1,79 | 0,80-4,07 | ns |
> = 3 | 29 (24,6%) | 2,51 | 1,17-5,45 | 0,01 |
POLYPHARMACY | Â | Â | Â | Â |
NO | 27 (7,6%) | Ref | Â | Â |
YES | 55 (57,9%) | 16,65 | 9,12-30,58 | <0.0001 |
BREAST SURGERY | Â | Â | Â | Â |
BREAST CONSERVING SURGERY | 29 (23,2%) | Ref | Â | Â |
MASTECTOMY | 53 (16,4%) | 0.65 | 0,38-1,11 | ns |
AXILLARY SURGERY | Â | Â | Â | Â |
NO AXILLARY SURGERY | 5 (12,5%) | Ref | Â | Â |
SENTINEL NODE BIOPSY | 31 (17,2%) | 1,46 | 0,49-4.60 | ns |
AXILLARY LYMPH NODE DISSECTION | 46 (20,1%) | 1,76 | 0,61-5,43 | ns |
NEOADJUVANT CHEMOTHERAPY | Â | Â | Â | Â |
NO NEOADJUVANT TREATMENT | 76 (17,4%) | Ref | Â | Â |
NEOADJUVANT CHEMOTHERAPY | 6 (46,1%) | 4,06 | 1,17-13,92 | <0,05 |
TNM STAGE | Â | Â | Â | Â |
IN SITU | 4 (23,5%) | Â | Â | Â |
I | 27 (16,1%) | Ref | Â | Â |
II | 25 (13,9%) | 0,84 | 0,45-1,58 | ns |
III | 8 (20,5%) | 1,35 | 0,51-3,49 | ns |
IV | 1 (25%) | 1,74 | 0,07-19,99 | ns |
UNKNOWN | 17 (41,5%) | Â | Â | Â |
BMI | Â | Â | Â | Â |
<20 | 1 (25%) | 2,06 | 0,08-25,85 | ns |
20-25 | 12 (14%) | Ref | Â | Â |
>25 | 31 (23%) | 1,84 | 0,84-4,08 | ns |
UNKNOWN | 38 (17%) | Â | Â | Â |
SMOKING AT TIME OF DIAGNOSIS | Â | Â | Â | Â |
NO | 46 (16,7%) | Ref | Â | Â |
YES | 11 (35,5%) | 2,75 | 1,14-6,54 | <0,05 |
UNKNOWN | 25 (17,6%) | Â | Â | Â |